发明名称 |
Crystalline form of a succinate salt |
摘要 |
This invention relates to a new crystalline form of the succinate salt of the epithelial sodium channel (ENaC) blocker 3-(3-{2-[(E)-3,5-Diamino-6-chloro-pyrazine-2-carbonylimino]-1,3,8- triaza-spiro[4.5]decane-8-carbonyl}-benzenesulfonylamino)-propionic acid dipropylcarbamoylmethyl ester, pharmaceutical compositions comprising said crystalline form, uses of said crystalline form and pharmaceutical compositions, and methods for preparing said crystalline form. |
申请公布号 |
AU2013237073(A1) |
申请公布日期 |
2014.09.25 |
申请号 |
AU20130237073 |
申请日期 |
2013.03.15 |
申请人 |
NOVARTIS AG |
发明人 |
HOWSHAM, CATHERINE;LINDENBERG, CHRISTIAN;PERLBERG, ANETT;TUFILLI, NICOLA |
分类号 |
C07D471/10;A61K31/438;A61P11/00;A61P35/00 |
主分类号 |
C07D471/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|